Mayo Clinic-linked med device firm close to FDA OK
Here's a little from an interestng piece by Lindsay Patton on Dailyrx.com about Torax Medical's anti-acid reflux device.
Mayo Clinic helped launch Torax in 2003 and Mayo Medical Ventures has invested in the company in the past.
John Deedrick, a Rochester venture capitalist who previously worked with Mayo Clinic, is also on Torax's board of directors.
A FDA panel has given unanimous support to LINX, an implantable device to treat chronic and severe acid reflux. That means LINX is one step closer to being available for US patients.
The magnetic attraction between the beads work to resist the gastric pressure that causes acid reflux. But when people are eating, it allows food and liquids to pass into the stomach normally.
LINX is produced by Torax Medical, a medical device company based in Minnesota. The device has already been on the market in some European countries for two years.
LINX is not recommended for patients who need MRI scans, due to the magnetic nature of the beads.
Torax plans a follow-up study of 200 patients to test LINX's long-term safety and effectiveness.